Phaon Scientific

Phaon Scientific is a UK-based drug discovery and development consultancy that provides strategic and technical expertise to the global pharmaceutical and biotechnology sectors. Founded by Dr. Richard Weaver, a former AstraZeneca executive, the company specializes in ADME (Absorption, Distribution, Metabolism, and Excretion), pharmacokinetics (PK), and toxicology. Phaon Scientific operates using a virtual model, partnering with other organizations to advance drug candidates from early discovery through to clinical development. Their services include lead optimization, candidate selection, and the design of preclinical programs to minimize attrition in later stages. The company is particularly recognized for its expertise in small molecule drug discovery and its contributions to the field of targeted protein degradation.